FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Maraviroc

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 5 USDMF, 1 EU WC, 8 NDC API, 5 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

FINISHED DOSAGE FORMULATIONS

50 FDF Dossiers, 15 FDA Orange Book, 27 Europe, 2 Canada, 4 Australia, 2 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG, TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 1 Pharm-RX Chemical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 5 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 5 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 2 Ideal Cures, 1 Ingredion Pharma Solutions, 1 JJ Chemicals, 4 Kerry, 2 Keval Exports, 7 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 11 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders, 17 Coating Systems & Additives, 16 Thickeners and Stabilizers, 14 Disintegrants & Superdisintegrants, 14 Controlled & Modified Release, 12 Lubricants & Glidants, 9 Direct Compression, 9 Topical, 7 Co-Processed Excipients, 7 Granulation, 6 Taste Masking, 5 Solubilizers, 4 Film Formers & Plasticizers, 3 Parenteral, 3 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Rheology Modifiers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

2 FDF Dossiers

2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

$ Xls

Filters

TABLET;ORAL - 300MG

TABLET;ORAL - 150MG

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Maraviroc

Maraviroc

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

5 USDMF

1 EU WC

8 NDC API

5 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

FINISHED DOSAGE FORMULATIONS

50 FDF Dossiers

15 FDA Orange Book

27 Europe

2 Canada

4 Australia

2 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 300MG

TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

1 Pharm-RX Chemical

4 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Kirsch Pharma

5 Actylis

1 Aeon Procare

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 BASF

1 Bioplus Life Sciences

1 CD Formulation

5 Corel Pharma Chem

3 DFE Pharma

1 Esteem Industries

1 Finar

7 Gangwal Chemicals

2 Ideal Cures

1 Ingredion Pharma Solutions

1 JJ Chemicals

4 Kerry

2 Keval Exports

7 Microlex e.U

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

11 Roquette

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Silverline Chemicals

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders

17 Coating Systems & Additives

16 Thickeners and Stabilizers

14 Disintegrants & Superdisintegrants

14 Controlled & Modified Release

12 Lubricants & Glidants

9 Direct Compression

9 Topical

7 Co-Processed Excipients

7 Granulation

6 Taste Masking

5 Solubilizers

4 Film Formers & Plasticizers

3 Parenteral

3 Emulsifying Agents

3 Chewable & Orodispersible Aids

1 API Stability Enhancers

TABLET;ORAL - 25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons